Replies to post #336 on Vicarious Surgical Inc (RBOT)

[timteo]

In conjunction, Vicarious Surgical is providing a regulatory update. Based upon the Company’s recent pre-submission communications with the U.S. Food and Drug Administration (“FDA”) to gain alignment on the clinical and regulatory pathway for the Vicarious System, the Company intends to pursue a pre-market trial to collect human clinical data for inclusion in a De Novo classification request of the Vicarious System to the FDA for its initial indication of ventral hernia repair.